Keywords
Human papillomavirus
meta-analysis
Data Availability Statement
All data generated or analyzed during this study are included in this published article and its supplementary materials.
Systematic review registration: PROSPERO CRD420261283152.
How to Cite
Abstract
Background: Human papillomavirus (HPV) infection is a major public health concern in Cameroon, where cervical cancer remains the second leading cause of cancer-related morbidity and mortality among women. Despite the availability of effective preventive measures, their uptake remains suboptimal and is influenced by population-level knowledge and awareness. This study aimed to synthesize existing evidence on HPV-related knowledge and its associated factors in Cameroon. Methods: This review included studies assessing knowledge of HPV as a sexually transmitted infection (STI), its causal role in cervical cancer, and overall good HPV knowledge. A comprehensive and systematic search was conducted across PubMed, Scopus, Web of Science, Embase, the Cochrane Library, and local online databases. Study quality was appraised using the Joanna Briggs Institute critical appraisal tool. Pooled prevalence estimates were calculated using random-effects models (DerSimonian and Laird). Heterogeneity was assessed using the I² statistic and explored through subgroup analyses. Results: A total of 32 studies involving 13, 457 participants were included. The pooled prevalence of overall good HPV knowledge was 27.4% (95% CI: 7.6–63.2; 7 studies; n = 3,312), with considerable heterogeneity (I² = 99.3%). Knowledge of HPV as a cause of cervical cancer was 27.9% (95% CI: 15.8–44.4; 26 studies; n = 8,688), while knowledge of HPV as an STI was 47.1% (95% CI: 31.4–63.5; 18 studies; n = 9,040). Healthcare workers demonstrated the highest levels of knowledge (80.2% for HPV as an STI; 78.7% for HPV as a cause of cervical cancer), whereas students (43.4% and 10.2%, respectively) and women from the general population (30.6% and 19.9%, respectively) showed substantially lower levels. Factors associated with poor knowledge included Christian affiliation (OR = 1.46; 95% CI: 0.08–26.06) and secondary level education (OR = 1.32; 95% CI: 0.66–2.63), although these associations were non-significant. Conclusions: This study reveals that, HPV-related knowledge in Cameroon remains low, particularly regarding the causal link between HPV and cervical cancer. These findings highlight the urgent need for targeted, context-specific educational interventions and strengthened public health strategies to improve awareness and uptake of HPV prevention measures.
References
[1] Guenou E, Wakam Nkontchou B, Vouking Zambou M, Buh Nkum C, Mfoulou Minso AC, Napa YL, et al. Acceptability and Feasibility of Human Papillomavirus Vaccine Introduction in Cameroon: A Mixed-Methods Study. Cureus. 2024;16:e60723. Doi:10.7759/cureus.60723
[2] Anni NS, Rehman N, Nyambi A, Musiwa A, Graham T, Dine RD, et al. Knowledge, attitudes, and practices towards Human Papilloma Virus and uptake of HPV vaccine: A protocol for a systematic review. Karimi-Sari H, editor. PLOS ONE. 2024;19:e0313887. https://doi.org/10.1371/journal.pone.0313887
[3] Mapoko BSE, Bell ED, Batoum V, Okobalemba EA, Fossa LT, Djampou E, et al. Knowledge, Attitudes, and Practices of University Students in a Cameroonian State University Regarding Cervical Cancer. J Cancer Ther. 2025;16:394–401. Doi:10.4236/jct.2025.1610029
[4] Wamai RG, Ayissi CA, Oduwo GO, Perlman S, Welty E, Manga S, et al. Assessing the Effectiveness of a Community-Based Sensitization Strategy in Creating Awareness About HPV, Cervical Cancer and HPV Vaccine Among Parents in North West Cameroon. J Community Health. 2012;37:917–26. https://doi.org/10.1007/s10900-012-9540-5
[5] Njoh AA, Waheed D-E-N, Kedakse TSNJ, Ebongue LJ, Kongnyuy EJ, Amani A, et al. Overcoming challenges and achieving high HPV vaccination uptake in Cameroon: lessons learned from a gender-neutral and single-dose program and community engagement. BMC Public Health. 2025;25:1696. https://doi.org/10.1186/s12889-025-22776-3
[6] Elit L, Ngalla C, Afugchwi GM, Tum E, Domgue JF, Nouvet E. Assessing knowledge, attitudes and belief toward HPV vaccination of parents with children aged 9–14 years in rural communities of Northwest Cameroon: a qualitative study. BMJ Open. 2022;12:e068212. https://doi.org/10.1136/bmjopen-2022-068212
[7] McCarey C, Pirek D, Tebeu PM, Boulvain M, Doh AS, Petignat P. Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC Womens Health. 2011;11:45. https://doi.org/10.1186/1472-6874-11-45
[8] Ayissi CA, Wamai RG, Oduwo GO, Perlman S, Welty E, Welty T, et al. Awareness, Acceptability and Uptake of Human Papilloma Virus Vaccine Among Cameroonian School-Attending Female Adolescents. J Community Health. 2012;37:1127–35. https://doi.org/10.1007/s10900-012-9554-z
[9] Haddison E, Tambasho A, Kouamen G, Ngwafor R. Vaccinators’ Perception of HPV Vaccination in the Saa Health District of Cameroon. Front Public Health. 2022;9:748910. https://doi.org/10.3389/fpubh.2021.748910
[10] Koanga MM, Ngono NA, Wandjis A, Dongang NR, Donfack TH, Nganwa G, et al. Sexual behaviour: human papilloma virus and cervical cancer risk among university students in cameroon. Afr J Haematol Oncol. 2010;1:115–21.
[11] Wamai RG, Ayissi CA, Oduwo GO, Perlman S, Welty E, Welty T, et al. Awareness, knowledge and beliefs about HPV, cervical cancer and HPV vaccines among nurses in Cameroon: An exploratory study. Int J Nurs Stud. 2013;50:1399–406. https://doi.org/10.1016/j.ijnurstu.2012.12.020
[12] Sossauer G, Zbinden M, Tebeu P-M, Fosso GK, Untiet S, Vassilakos P, et al. Impact of an Educational Intervention on Women’s Knowledge and Acceptability of Human Papillomavirus Self-Sampling: A Randomized Controlled Trial in Cameroon. PLOS ONE. Public Library of Science; 2014;9:e109788. https://doi.org/10.1371/journal.pone.0109788
[13] Ekane GEH, Obinchemti TE, Nguefack CT, Nkambfu DM, Tchounzou R, Nsagha D, et al. Pap Smear Screening, the Way Forward for Prevention of Cervical Cancer? A Community Based Study in the Buea Health District, Cameroon. Open J Obstet Gynecol. 2015;05:226–33. https://doi.org/10.4236/ojog.2015.54033
[14] Mforteh AAA, Julius DS, Merlin B, Ako TW, Walters PD, Tiku EC, et al. Factors Associated with Cervical Cancer Screening and Prevalence of Premalignant Cervical Lesions in a Rural Setting in Cameroon: a Cross-Sectional Analytical Study: Cervical cancer screening and prevalence of premalignant lesions. Health Res Afr. 2023;1:32–8. https://doi.org/10.5281/hra.v1i4(Suppl%201).4992
[15] Tarkang E, Dzah SM, Adu-Poku F, Nzegge MM, Dadah E, Ahiabor SY. Sexual Behavior and its Association with Knowledge Regarding HIV or AIDS Among Migrant Road Construction Workers in a Rural Setting of Cameroon. J Prev Med Health Care. JSciMed Central; 2017;1:1012. https://doi.org/10.47739/2576-0084/1012
[16] Nkfusai NC, Cumber SN, Anchang-Kimbi JK, Nji KE, Shirinde J, Anong ND. Assessment of the current state of knowledge and risk factors of cervical cancer among women in the Buea Health District, Cameroon. Pan Afr Med J . 2019 [cited 2026 Feb 17];33. https://doi.org/10.11604/pamj.2019.33.38.16767
[17] Fru CN, Andrew T, Cho FN, Thierry T, Fru PN. Determinants of Awareness and Knowledge on Cervical Cancer among Women in Buea- Cameroon. Int J Res Rep Gynaecol. 2020;3:89–102.
[18] Sobe LE. Knowledge, Attitudes and Practices Towards Human Papillomavirus (HPV) and HPV Vaccination among Students at Higher Institutions of Learning in Buea, South West Region of Cameroon: A Cross-Sectional Study. Rev. 2025;doi: 10.21203/rs.3.rs-5833643/v1. https://doi.org/10.21203/rs.3.rs-5833643/v1
[19] Afegenwi MH, Feduma AS, Emilio BB, Notang MI. Human Papilloma Virus (HPV) Infection and Vaccination: Knowledge, Attitudes and Practices among Young Adults Attending Universities in Cameroon. J Adv Microbiol. 2023;23:1–14. https://doi.org/10.9734/jamb/2023/v23i4716
[20] Zeuko’o EM, Tendem A, Ngounou E, Egbe TO. Knowledge of cervical cancer, associated risk factors, and practice of cervical cancer screening among female students in higher education institutions in Buea, Cameroon, a cross-sectional study. Clin Epidemiol Glob Health. 2025;36:102173. https://doi.org/10.1016/j.cegh.2025.102173
[21] Njoh AA, Bolio A, Venczel L, Libwea JN, Waheed D-N, Kongnyuy EJ, et al. Key players and determinants improving human papillomavirus vaccination coverage in Cameroon: a cross-sectional nationwide health workers survey. Vaccine. 2026;69:128006. https://doi.org/10.1016/j.vaccine.2025.128006
[22] Ntonifor MM-N, Tazinkeng NN, Kemah B-L, Claudia NE, Sonia YK, Nchinjoh SC, et al. Factors associated with parental hesitancy towards the human papillomavirus vaccine: a cross-sectional study. Sci Rep. 2025;15:18284. https://doi.org/10.1038/s41598-025-94067-1
[23] Maïdadi FM, Bouda A, Akwa L, Mbinyui MS, Mohamadou M, Engowei MC, et al. Knowledge, Attitudes And Perception Of Women Regarding Cervical Cancer In The City Of Yaoundé, Cameroon. Br J Med Health Sci. British Journal of Medical & Health Sciences; 2020;2:203–10.
[24] Kindong N-M, Akom N, Nkwain T, Nyuykighan C, Sama O, Kennedy A. Perception on Cervical Cancer, Screening Practices and its Determinants AmongWomen Aged 15-49 in Cibec and Bloc Banen Health Areas, Bonaberi Health District, Douala. Gynecol Women’s Health Care. 2025;6:1–12. https://doi.org/10.47485/2766-5879.1022
[25] Layu D, Kifu NF, Dohbit SJ, Nkfusai CN, Bede F, Shirinde J, et al. Assessing the uptake of cervical cancer screening among women aged 25-65 years in Kumbo West Health District, Cameroon. Pan Afr Med J. 2019;33. https://doi.org/10.11604/pamj.2019.33.106.16975
[26] Tassang A, Celestina NF, Dadao F, Domkao P, Tchounzou R, Akintunde TY, et al. Cervical cancer screening in Doukoula- the far north region of Cameroon. World J Adv Res Rev. 2023;20:404–11. https://doi.org/10.30574/wjarr.2023.20.2.2033
[27] Tassang A, Fru CN, Brady MR, Cho FN, Thierry T, Paulette NF, et al. Knowledge and Risk Factors of Cervical Cancer among Women in Towns of Fako Division- Cameroon. J Adv Med Med Res. 2021;81–91. https://doi.org/10.9734/jammr/2021/v33i1631004
[28] Dakenyo RD, Kenfack B, Vogue N, Tsakoue EF, Ebode ME, Cumber SN. Connaissances, attitudes et pratiques des femmes en âge de procréer du District de Santé de la Mifi sur la prévention du cancer du col de l’utérus, Cameroun. Pan Afr Med J. 2018;31. https://doi.org/10.11604/pamj.2018.31.172.16320
[29] Eta V, Mh S, Njc A, Ds N. Knowledge, Attitudes and Practices towards Cervical Cancer Prevention among Female Sex Workers in the Douala Municipality, Cameroon. Int J Res Biol Sci. 2024;1:47–62.
[30] Wabo B, Nsagha DS, Nana T, Pokam BDT, Njiomenie GF, Guemdjom WP, et al. Knowledge on cervical cancer and screening tests among women at two reference hospitals in Yaounde, Cameroon. Int J Biol Chem Sci. 2019;13:1487–95. https://doi.org/10.4314/ijbcs.v13i3.22
[31] Ambori AC, Peter T, Ngounou E, Elombo S, Ndaka W, Tanue EA, et al. Knowledge on Cervical Cancer and its Prevention Amongst Females Attending Limbe Regional Hospital in the South-West Region of Cameroon. Int J Res Sci Innov. 2025;12:2060–70. https://doi.org/10.51244/IJRSI.2025.1210000182
[32] Georges K, Herve AN, Simo RT, Jeremie M, Charlette N. Knowledge and behavior of women on cervical cancer in the northern region of Cameroon. Front Women’s Health. 2017;2:1–4. https://doi.org/10.15761/FWH.1000131
[33] Eakin C, Ekollo R, Nembulefack D, Halle-Ekane G, Tangui G, Brady R, et al. Cervical Cancer Screening Beliefs and Prevalence of LSIL/HSIL Among a University-Based Population in Cameroon. J Low Genit Tract Dis. 2018;22:274–9. https://doi.org/10.1097/LGT.0000000000000433
[34] Crofts V, Flahault E, Tebeu PM, Untiet S, Boulvain M, Vassilakos P, et al. Education efforts may contribute to wider acceptance of human papillomavirus self-sampling. Int J Womens Health. 2015;7:149–54. https://doi.org/10.2147/IJWH.S56307
[35] Berner A, Hassel SB, Tebeu P-M, Untiet S, Kengne-Fosso G, Navarria I, et al. Human Papillomavirus Self-Sampling in Cameroon: Women’s Uncertainties Over the Reliability of the Method Are Barriers to Acceptance. J Low Genit Tract Dis. 2013;17:235–41. https://doi.org/10.1097/LGT.0b013e31826b7b51
[36] JBI Critical Appraisal Tools. JBI. 2026. https://jbi.global/critical-appraisal-tools. Accessed 29 Mar 2026
[37] Nwaozuru U, Obiezu-Umeh C, Uzodufa SA, Salako A, Akinsolu FT, Ezechi OC, et al. Systematic review and meta-analysis of the prevalence of oral cancer in Nigeria. BMC Oral Health. 2025;25:414. https://doi.org/10.1186/s12903-025-05724-w
[38] Abraham G, Gelana B, Yitbarek K, Morankar S. Prevalence of domestic violence in a time of catastrophic disease outbreaks including COVID-19 pandemic: a systematic review protocol. Syst Rev. 2022;11:46. https://doi.org/10.1186/s13643-022-01920-9
[39] Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29:3046–67. https://doi.org/10.1002/sim.4040
[40] R Core Team. R: A Language and Environment for Statistical Computing. R Found. Stat. Comput. Austria. 2024. https://www.R-project.org/. Accessed 30 May 2024
[41] Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ.1997;315:629–34. https://doi.org/10.1136/bmj.315.7109.629
[42] Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088.
[43] Duval S, Tweedie R. Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis. Biometrics. 2000;56:455–63. https://doi.org/10.1111/j.0006-341X.2000.00455.x
[44] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. British Medical Journal Publishing Group; 2021;372:n71. https://doi.org/10.1136/bmj.n71
[45] Halle-Ekane GE, Nembulefack DK, Orock GE, Fon PN, Tazinya AA, Tebeu PM. Knowledge of Cervical Cancer and Its Risk Factors, Attitudes and Practices towards Pap Smear Screening among Students in the University of Buea, Cameroon. J Cancer Tumor Int. 2018;7:1–11. https://doi.org/10.9734/JCTI/2018/43965
[46] Tagne Simo R, Christian Kamnang T, Léonie Marthe Ghomsi S, Jacqueline F, Armel Hervé Nwabo K, Paul F Seke E, et al. Primary and Secondary Prevention of Cervical Cancer at Two District Health Centres in the West Region of Cameroon. Int J Cancer Clin Res. 2020;7:1–7. https://doi.org/10.23937/2378-3419/1410136
[47] Alghalyini B, Zaidi ARZ, Meo SA, Faroog Z, Rashid M, Alyousef SS, et al. Awareness and knowledge of human papillomavirus, vaccine acceptability and cervical cancer among college students in Saudi Arabia. Hum Vaccines Immunother. 2024;20:2403844. https://doi.org/10.1080/21645515.2024.2403844
[48] Al-leimon A, Al-leimon O, Abdulhaq B, Al-salieby F, Jaber A-R, Saadeh M, et al. From awareness to action: Unveiling knowledge, attitudes and testing strategies to enhance human papillomavirus vaccination uptake in Jordan. J Virus Erad. 2024;10:100380. https://doi.org/10.1016/j.jve.2024.100380
[49] Asgedom YS, Kebede TM, Seifu BL, Mare KU, Asmare ZA, Asebe HA, et al. Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis. Hum Vaccines Immunother. 2024;20:2326295. https://doi.org/10.1080/21645515.2024.2326295
[50] Asmelash D, Zewdia WF, Abebe GF, Girma D, Mohammed AH, Asres A. Prevalence and predictors of parental willingness to vaccinate daughters against human papillomavirus in Sub-Saharan Africa: a systematic review and meta-analysis. Front Public Health. 2025;13:1486262. https://doi.org/10.3389/fpubh.2025.1486262
[51] Kailemia PN, Mukami V. Exploring intersectional determinants of, and interventions for, low uptake of human papillomavirus vaccine in sub-Saharan Africa: a scoping review protocol. BMJ Open. 2025;15:e083848. https://doi.org/10.1136/bmjopen-2023-083848
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Journal of Public Health and Preventive Medicine